Eisai Wins FDA Approval For Novel, Once-Daily Seizure Drug Fycompa
This article was originally published in The Pink Sheet Daily
Executive Summary
Eisai’s Fycompa becomes only the second drug with a new mechanism of action approved by FDA for epilepsy in the last decade.